Tectonic Therapeutic, Inc. (TECX) stock
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$21.96−0.01 (-0.05%)
Close on Nov 11, 2026Market cap $429.30MP/E –Yield 0.00%
Tectonic Therapeutic cash
Cash and short-term investments held at the end of each period.
Tectonic Therapeutic's cash was $234.67M at Sep 30, 2026. For fiscal 2025 it was $253.80M, up 79.0% from the year before. The highest annual figure on record is $260.17M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.80M | +79.0% |
| FY2024 | Dec 31, 2024 | $141.83M | +383.1% |
| FY2023 | Dec 31, 2023 | $29.36M | -19.7% |
| FY2022 | Dec 31, 2022 | $36.55M | -80.8% |
| FY2021 | Dec 31, 2021 | $190.06M | -26.9% |
| FY2020 | Dec 31, 2020 | $260.17M | +38.7% |
| FY2019 | Dec 31, 2019 | $187.54M | +47.9% |
| FY2018 | Dec 31, 2018 | $126.79M | +2017.8% |
| FY2017 | Dec 31, 2017 | $5.99M | +11.3% |
| FY2016 | Dec 31, 2016 | $5.38M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $234.67M | -12.6% |
| Q2 FY2026 | Jun 30, 2026 | $227.07M | -21.0% |
| Q1 FY2026 | Mar 31, 2026 | $236.89M | -22.6% |
| Q4 FY2025 | Dec 31, 2025 | $253.80M | +79.0% |
| Q3 FY2025 | Sep 30, 2025 | $268.44M | +68.7% |
| Q2 FY2025 | Jun 30, 2025 | $287.38M | +55.2% |
| Q1 FY2025 | Mar 31, 2025 | $306.25M | +1533.5% |
| Q4 FY2024 | Dec 31, 2024 | $141.83M | +383.1% |
| Q3 FY2024 | Sep 30, 2024 | $159.10M | +2413.3% |
| Q2 FY2024 | Jun 30, 2024 | $185.12M | +1139.8% |
| Q1 FY2024 | Mar 31, 2024 | $18.75M | -74.1% |
| Q4 FY2023 | Dec 31, 2023 | $29.36M | -19.7% |
| Q3 FY2023 | Sep 30, 2023 | $6.33M | -94.5% |
| Q2 FY2023 | Jun 30, 2023 | $14.93M | -88.7% |
| Q1 FY2023 | Mar 31, 2023 | $72.33M | -55.3% |
| Q4 FY2022 | Dec 31, 2022 | $36.55M | -80.8% |
| Q3 FY2022 | Sep 30, 2022 | $115.97M | -42.4% |
| Q2 FY2022 | Jun 30, 2022 | $132.41M | -41.5% |
| Q1 FY2022 | Mar 31, 2022 | $161.66M | -30.6% |
| Q4 FY2021 | Dec 31, 2021 | $190.06M | -26.9% |
| Q3 FY2021 | Sep 30, 2021 | $201.37M | -8.3% |
| Q2 FY2021 | Jun 30, 2021 | $226.44M | -7.3% |
| Q1 FY2021 | Mar 31, 2021 | $233.03M | -9.6% |
| Q4 FY2020 | Dec 31, 2020 | $260.17M | +38.7% |
| Q3 FY2020 | Sep 30, 2020 | $219.55M | +6.4% |
| Q2 FY2020 | Jun 30, 2020 | $244.38M | +170.5% |
| Q1 FY2020 | Mar 31, 2020 | $257.70M | +137.6% |
| Q4 FY2019 | Dec 31, 2019 | $187.54M | +47.9% |
| Q3 FY2019 | Sep 30, 2019 | $206.36M | +48.9% |
| Q2 FY2019 | Jun 30, 2019 | $90.35M | -41.7% |
| Q1 FY2019 | Mar 31, 2019 | $108.48M | +87.3% |
| Q4 FY2018 | Dec 31, 2018 | $126.79M | +2017.8% |
| Q3 FY2018 | Sep 30, 2018 | $138.55M | +15243.6% |
| Q2 FY2018 | Jun 30, 2018 | $154.99M | +3527.2% |
| Q1 FY2018 | Mar 31, 2018 | $57.93M | +976.5% |
| Q4 FY2017 | Dec 31, 2017 | $5.99M | – |
| Q3 FY2017 | Sep 30, 2017 | $903.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $4.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.38M | – |
See a number that looks wrong?